Home/Theradiag/Bertrand de Castelnau
BD

Bertrand de Castelnau

Chief Executive Officer

Theradiag

Theradiag Pipeline

DrugIndicationPhase
Lisa-Tracker ExtensionsAutoimmune DiseasesDevelopment/CE Marking
Prestizia Oncology PanelsSolid TumorsCommercial/Market Expansion
Digital PCR Assay DevelopmentOncology & Infectious DiseasesR&D/Validation
Companion Diagnostic Co-DevelopmentOncology TargetsPartnership/Regulatory